These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9476918)

  • 21. The feasibility of 225Ac as a source of alpha-particles in radioimmunotherapy.
    Geerlings MW; Kaspersen FM; Apostolidis C; van der Hout R
    Nucl Med Commun; 1993 Feb; 14(2):121-5. PubMed ID: 8429990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted alpha-therapy for control of micrometastatic prostate cancer.
    Li Y; Russell PJ; Allen BJ
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):459-68. PubMed ID: 15161444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetrating the Barriers to Successful α-Radioimmunotherapy.
    Carlin S
    J Nucl Med; 2018 Jun; 59(6):934-936. PubMed ID: 29545376
    [No Abstract]   [Full Text] [Related]  

  • 25. [9th Symposium on Targeted Alpha Therapy].
    Kaku Igaku; 2015 Nov; 52(4):367-8. PubMed ID: 27263271
    [No Abstract]   [Full Text] [Related]  

  • 26. Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides.
    Henriksen G; Schoultz BW; Michaelsen TE; Bruland ØS; Larsen RH
    Nucl Med Biol; 2004 May; 31(4):441-9. PubMed ID: 15093814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future Vistas in Alpha Therapy of Infectious Diseases.
    Dadachova E
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S49-S52. PubMed ID: 31427256
    [No Abstract]   [Full Text] [Related]  

  • 28. Production of actinium-225 for alpha particle mediated radioimmunotherapy.
    Boll RA; Malkemus D; Mirzadeh S
    Appl Radiat Isot; 2005 May; 62(5):667-79. PubMed ID: 15763472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted alpha therapy of prostate cancer.
    Allen BJ; Li Y; Rizvi SM; Russell PJ
    Methods Mol Med; 2003; 81():333-57. PubMed ID: 12725130
    [No Abstract]   [Full Text] [Related]  

  • 30. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
    Sharkey RM; Goldenberg DM
    J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuances.
    Basu S; Banerjee S
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1244-1246. PubMed ID: 28364163
    [No Abstract]   [Full Text] [Related]  

  • 32. The Future of Radioligand Therapy: α, β, or Both?
    Haberkorn U; Giesel F; Morgenstern A; Kratochwil C
    J Nucl Med; 2017 Jul; 58(7):1017-1018. PubMed ID: 28408527
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhanced loading efficiency and retention of 225Ac in rigid liposomes for potential targeted therapy of micrometastases.
    Chang MY; Seideman J; Sofou S
    Bioconjug Chem; 2008 Jun; 19(6):1274-82. PubMed ID: 18505278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter from the Editors.
    Sathekge MM; Bouchelouche K
    Semin Nucl Med; 2020 Mar; 50(2):115-117. PubMed ID: 32172794
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of solid tumors by interstitial release of recoiling short-lived alpha emitters.
    Arazi L; Cooks T; Schmidt M; Keisari Y; Kelson I
    Phys Med Biol; 2007 Aug; 52(16):5025-42. PubMed ID: 17671351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monoclonal antibodies. General approach and radioimmunotherapy].
    Sousa O; Vieira E
    Acta Med Port; 1998 Apr; 11(4):337-47. PubMed ID: 9644845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The magic-bullet: moving the concept towards reality – part II.
    Elgqvist J
    Curr Radiopharm; 2011 Oct; 4(4):281-2. PubMed ID: 22202150
    [No Abstract]   [Full Text] [Related]  

  • 38. Technological advances in radioimmunotherapy.
    Dearling JL; Pedley RB
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):457-69. PubMed ID: 17537620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclotron production of Ac-225 for targeted alpha therapy.
    Apostolidis C; Molinet R; McGinley J; Abbas K; Möllenbeck J; Morgenstern A
    Appl Radiat Isot; 2005 Mar; 62(3):383-7. PubMed ID: 15607913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.
    Henriksen G; Breistøl K; Bruland ØS; Fodstad Ø; Larsen RH
    Cancer Res; 2002 Jun; 62(11):3120-5. PubMed ID: 12036923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.